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The environmental dioxin 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is classified as a Group 1 human
carcinogen and teratogenic agent. We hypothesize that TCDD-induced oxidative stress may also interfere
with mitochondrial ATP-sensitive potassium channels (mitoKATP), which are known to regulate and to
be regulated by mitochondrial redox state. We investigated the effects of an acute treatment of male
Wistar rats with TCDD (50 mg/kg i.p.) and measured the regulation of cardiac mitoKATP. While the
function of cardiac mitochondria was slightly depressed, mitoKATP activity was 52% higher in animals
treated with TCDD. The same effects were not observed in liver mitochondria isolated from the same
animals. Our data also shows that regulation of mitochondrial ROS production by mitoKATP activity is
different in both groups. To our knowledge, this is the first report to show that TCDD increases mitoKATP
activity in the heart, which may counteract the increased oxidative stress caused by the dioxin during
acute exposure.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
The very persistent environmental toxin 2,3,7,8-Tetra-
chlorodibenzo-p-dioxin (TCDD) harbors a low breakdown rate; in
fact, this dioxin is omnipresent in the global environment and has
an estimated half-life of 7.6 years in humans (Michalek and
Tripathi, 1999). The US Environmental Protection Agency (EPA)
has estimated that more than 90% of total human exposure to
dioxins and dioxin-like compounds e polychlorinated dibenzo-
p-dioxins and polychlorinated dibenzofurans (PCDD/Fs) e occurs
through food consumption (U.S. EPA. Dioxin Reassessment.DP, adenosine diphosphate;
e triphosphate; BSA, bovine
e electric potential; DMSO,
PH, dinitrophenylhydrazine;
ineethanesulfonic acid; HRP,
ht/body weight; LW/BW, liver
ensitive potassium channels;
ry control ratio; ROS, reactive
2,3,7,8-Tetrachlorodibenzo-p-
sphonium cation.
All rights reserved.National Academy of Sciences (NAS) Review Draft 2004. U.S.
Environmental Protection Agency, 2004), although water and, to a
lesser extent, inhalation and skin absorption can also be exposure
sources (Mandal, 2005). PCDD/Fs can also originate from natural
sources such as forest fires; however, the more significant origins of
dioxins include waste incineration, pesticide manufacture, chlorine
bleaching of pulp and paper, municipal and industrial incineration,
and metal refining (Hays and Aylward, 2003).
Low doses of TCDD administered to rodents by different routes
cause tumors at multiples sites (Knerr and Schrenk, 2006).
Different mechanisms have been proposed for the carcinogenic
effect of TCDD, including binding and activation of the cytosolic
aromatic hydrocarbon receptor (AhR) (Ray and Swanson, 2009), a
ligand-activated nuclear transcription factor. Also, TCDD increases
reactive oxygen species (ROS) generation, which results in lipid
peroxidation, leading to cell membrane disruption, DNA and pro-
tein damage and calcium homeostasis disruption in various rodent
tissues (Aly and Khafagy, 2011; Hassoun et al., 2000; Shertzer et al.,
2006). Generation of ROS such as hydroxyl radical, superoxide
anion and hydrogen peroxide appear to be involved in TCCD-
induced oxidative damage (Stohs et al., 1986).
Mitochondria may mediate, at least in part, TCDD-induced
oxidative stress effects. Nohl et al. (1989) demonstrated that
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in vitro addition of TCDD to bovine heart mitochondria (Nohl et al.,
1989). Exposure of C2C12 myocytes to TCDD results in inhibition of
mitochondrial transcription, disruption of mitochondrial trans-
membrane potential (DJ) and altered calcium homeostasis (Biswas
et al., 2008). In addition to developing an increased resistance to
apoptosis, TCDD-treated C2C12 cells also acquired increased inva-
sive capacity, none of the effects being dependent on the AhR
(Biswas et al., 2008). These findings suggest that TCDD toxicity may
present a mitochondrial component. In fact, mitochondria are a
plausible target for several xenobiotics and an excellent in vitro
model to predict compound toxicity (Pereira et al., 2009).
The mitochondrial Kþ cycle consists of electrophoretic Kþ uptake
and electroneutral Kþ efflux across the inner membrane (Garlid,
1996), the latter being mediated by a Kþ/Hþ antiporter and influx
is mediated by a mitochondrial ATP-sensitive potassium channels
(mitoKATP) (Garlid, 1996). Other potassium channels are present in
the inner mitochondrial membrane including a large conductance
Ca2þ-activated potassium channel (Siemen et al., 1999), the voltage-
gated Kv1.3 potassium channel (Szabo et al., 2005) and the twin-
pore domain TASK-3 potassium channel (Rusznak et al., 2008). The
putative functional roles of these several channels include the
modulation of mitochondrial matrix volume, respiration and mem-
brane potential (Szewczyk et al., 2009). In addition, the activity of
these channels can also modulate the generation of reactive oxygen
species (ROS) by mitochondria (Facundo et al., 2007). The molecular
identity ofmammalianmitoKATP is amatter of debate. ATP-sensitive
Kþ (KATP) channels were initially identified in the plasma mem-
brane of cardiac myocytes (Noma, 1983). These channels were
further distinguished by their specific localization within the cell.
Sarcolemmal (sarcKATP), nuclear (nucKATP) or mitochondrial
(mitoKATP) ATP sensitive potassium channels have been identified.
Although the mitoKATP was characterized (Inoue et al., 1991) and
later purified and partly reconstituted (Paucek et al., 1992), their
composition and nature is still debatable. Many research groups
propose that the channel has a structure similar to classical KATP
channels, based on the pharmacological sensitivities and immuno-
reactivity with specific antibodies. Also, it has been suggested that
the mitoKATP from rats heart include a Kþ inward rectifier (mitoKIR,
subunits Kir6.1 and Kirb 6.2) and sulfonylurea receptors (SURs,
namely SUR2) (Cuong et al., 2005; Suzuki et al., 1997).
The modulation of mitoKATP (O’Rourke, 2004) by pro-oxidant
xenobiotics with environmental relevance has received scarce
attention. The putative functional roles of mitoKATP include modu-
lation of mitochondrial matrix volume, mitochondrial respiration
and membrane potential. The activity of mitoKATP can also modu-
late the generation of ROS by mitochondria (Szewczyk et al., 2009).
Kowaltowski and co-workers proposed mitoKATP openers to
have direct effects on mitochondrial respiration, membrane poten-
tial and Ca2þ uptake under physiological conditions (Kowaltowski
et al., 2001). MitoKATP are redox-sensitive channels with higher
activity under increasingly oxidative conditions (Facundo et al.,
2007; Liu et al., 2002), suggesting a role of this channel in redox
mitochondrial signalling in the heart, where higher activity of this
channel has been described (Kowaltowski et al., 2001).
The hypothesis for the present work is that an acute TCDD
treatment causes oxidative damage to cardiac mitochondria result-
ing not only in mitochondrial damage, but also in an altered regu-
lation ofmitoKATP. Our hypothesis includes that increased activation
of mitoKATP would counteract TCDD-induced oxidative stress and
prevent further mitochondrial damage. The heart was focused in the
present work since the mitoKATP are an important component of
different cardiac signalling pathways that respond to alterations in
the redox state of the cell. One such pathway with clinical relevance
involves KATP on ischemic pre-conditioning (Queliconi et al., 2011).2. Material and methods
2.1. Reagents
All reagents used were of the highest grade of purity commercially available
(analytical grade or better), and all aqueous solutions were prepared in ultrapure
(type I) water. A 99% chemical pure TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)
from LGC Standards (Barcelona, Spain) was dissolved in dimethylsulphoxide (DMSO)
66.7 mg/ml. Diazoxide (DZX, in DMSO), 5-hydroxydecanoic acid (5-HD, in water)
stock solutions were prepared just prior to each experiment. Amplex Red (in DMSO)
and horseradish peroxidase type VI-A (HRP) provided by SigmaeAldrich, St. Louis,
MO, USA, rotenone (in DMSO), adenosine triphosphate (ATP, in water), glutamate/
malate and succinate (in water) solutions were kept as frozen aliquots.
For Western blotting assays, the primary antibody used was Rabbit Anti-DNP
(D9656) from Sigma (Portugal). The secondary antibody was Goat anti-rabbit IgG-
AP (sc-2007) from Santa Cruz Biotechnology Inc. (Portugal). The protein molecular
weight markers (Precision Plus Protein Dual Color Standards) were obtained from
Bio-Rad Laboratories, Inc., CA, USA, while the ECF substrate was obtained from
Amersham Biosciences, Buckinghamshire, England.
2.2. Animal care and ethical statement
All experiments involving animals were conducted in accordance with the Eu-
ropean convention for the protection of vertebrate animal used for experimental
and other scientific purposes (CETS no. 123 of 18 march 1986 and 2005 revision) and
the Commission Recommendation of 18 June 2007 on guidelines for the accom-
modation and care of animals used for experimental and other scientific purposes
(C (2007) 2525). The authors are accredited by the Federation of Laboratory Animal
Science Associations (FELASA) for animal experimentation. A limited number of
animals were used in the present study based on preliminary data obtained for liver
mitochondria and due to concerns in the use of a larger pool of animals with this
particular environmental toxicant. Male Wistar Han IGS rats were purchased from
Charles River (France). Animals were group-housed in type III-H cages (Tecniplast,
Italy) with appropriated corn cob bedding and environmental enrichment. Rats
were maintained in proper environmental requirements including room tempera-
ture set at 22 C, relative humidity at 45e65%, ventilationwith 15e20 changes/hour,
a12 h light/dark cycle, noise level <55 dB, and ad libitum access to standard rodent
food (4RF21 GLP certificate, Mucedola, Italy) and acidified water (at pH 2.6 with HCl,
in order to prevent bacterial growth). All animals were acclimated 10e14 days prior
to experiment initiation. For the current study, 10 week old rats (280e350 g) were
injected with TCDD (50 mg/kg of body weight) in DMSO or with an equivalent vol-
ume of DMSO alone (controls) via intraperitoneal injection (i.p.), 24 h before the
sacrifice. All animals were weighed at the beginning and end of the experimental
period. This dosing protocol was chosen based on previous studies (Choi et al., 2008;
Stohs et al., 1991). Non-fasted rats were euthanized by cervical dislocation between
9:00 and 10:00 AM to eliminate possible effects due to diurnal variation. Hearts
(about 0.8 g) and livers (about 10.0 g) were removed, weighed and placed in chilled
isolation medium containing 300 mM sucrose, 10 mMHEPES-KOH (7.2), 1 mM EGTA
and 1 mg/ml fatty acid free BSA.
2.3. Isolation of the cardiac mitochondrial fraction
Heart mitochondria were isolated from male Wistar rats (10 weeks old) as
previously described (Oliveira et al., 2001). After weighing, the hearts were imme-
diately excised and finely minced in an ice-cold isolation medium, with blood
removed. Minced blood-free tissue was then resuspended in 40 ml of isolation
medium supplied with 0.2 mg protease Type VIII (Sigma n P-5390) per gram of
tissue and homogenized with a tightly-fitted homogenizer (Teflon pestle:glass
homogenizer) for 2e3 min in order to minimize loss of mitochondrial membrane
integrity. The suspension was incubated for 1 min (4 C) and then re-homogenized.
The protease was then removed from the homogenate by centrifugation at 14,400
g for 5 min at 4 C. The supernatant was decanted and the pellet, essentially free of
protease, was gently homogenized to its original volume with a loose-fitting ho-
mogenizer. The suspension was centrifuged at 750 g for 10 min and the resulting
supernatant was centrifuged at 12,000 g for 10 min with washing medium
(300 mM sucrose, 10 mM HEPES-KOH (7.2)). The pellet was resuspended manually
using a paintbrush and washed twice at 12,000 g for 10 min, being then resus-
pended in 500 mL of washing medium. Mitochondrial protein content was deter-
mined by the Biuret method (Gornall et al., 1949) using BSA as standard.
Mitochondrial yield was also calculated as the mitochondrial protein obtained
divided by heart weight (100) and expressed in percentage (%). Samples were kept
on ice and used within 1 h of isolation to ensure mitoKATP activity and pharma-
cological regulation.
2.4. Detection of mitochondrial carbonyl groups
The protein reactive carbonyls in mitochondrial fraction were analyzed
according to previously published methods (Robinson et al., 1999) with slight
modifications. A determined volume of mitochondrial suspension (V) containing
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purpose, a volume (1V) of 12% sodium dodecyl sulfate (SDS) and two volumes (2V) of
20 mM DNPH prepared in 10% TFA was added to each sample, followed by a 20 min
incubation in the dark. After this period, a neutralization reaction with 1.5 volumes
(1.5 V) of 2M Tris and 18% of b-mercaptoethanol was performed. A negative control
with 20 mM NaBH4, which reduces carbonyl groups to alcohols, was simultaneously
prepared for each sample. After dilution in Tris buffer solution to obtain a final
concentration of 0.1 mg/ml, 5 mg mitochondrial protein were loaded into a 12%
polyacrylamide gel using SDS-PAGE electrophoresis and probed against protein
carbonyl groups (anti-DNP, 1:2500 overnight at 4 C).
2.5. Mitochondrial respiratory activity
Oxygen consumption of isolatedmitochondria was monitored polarographically
with a Clark-type oxygen electrode connected to a suitable recorder. The suspension
was under controlled temperature (37 C) and constant stirring in 1 mL of reaction
medium (130 mM sucrose, 50 mM KCl, 5 mM KH2PO4, 100 mM EGTA, 5 mM HEPES-
KOH pH 7.4) in a thermostatic water-injected closed chamber. Mitochondria
(0.5 mg) were incubated for 1 min and energized with either 2 mM of glutamate/
malate or 2 mM of succinate plus 3 mM rotenone. After reaching steady-state oxygen
consumption, 100 nmol ADP was added to initiate state 3 respiration.
The respiratory control ratio (RCR), an indication of mitochondrial integrity, and
the ADP/O ratio, a measure of the efficiency of the phosphorylation system, were
calculated as described previously (Chance and Williams, 1955).
2.6. Determination of mitochondrial transmembrane potential (DJ)
The DJwas indirectly estimated by evaluating the transmembrane distribution
of the lipophilic cation tetraphenylphosphonium (TPPþ) using a TPPþ selective
electrode in combination with an Ag/AgCl saturated reference electrode as previ-
ously described (Oliveira et al., 2000). Both the TPPþ electrode and the reference
electrode were inserted into a chamber at 37 C with magnetic stirring in 1 mL of
medium (130 mM sucrose, 50 mM KCl, 5 mM KH2PO4, 100 mM EGTA, 5 mM HEPES-
KOH pH 7.4) containing 3 mM TPP-Cl. The DJ (in mV) was estimated without any
binding correction, according to Kamo et al. (Kamo et al., 1979) and as previously
described (Sardao et al., 2002). Mitochondria (0.5 mg) were incubated for 1 min and
energized with 2 mM of glutamate/malate or 2 mM of succinate plus 3 mM rotenone.
After reaching a steady-state distribution of TPPþ, 100 nmol ADP was added and DJ
fluctuations were recorded. To confirm state 3 respiration results, the phosphory-
lative lag-phase was also calculated as the time in seconds taken by the mito-
chondrial suspension to phosphorylate the added ADP and restore the basal DJ
values.
2.7. Measurement of mitochondrial matrix volume changes modulating the
mitoKATP activity
Light-scattering changes due to Kþ uptake and swelling in mitochondrial sus-
pensions (Kowaltowski et al., 2001; Facundo et al., 2007) were followed over time
using a Perkin Elmer LS-55B Fluorescence Spectrometer operating with excitation
and emission wavelengths both set at 520 nm and slit widths of 2.5 nm with
continuous stirring at 37 C. Mitochondria (0.25mg protein/ml) were suspended in a
buffered salt medium containing 130 mM KCl, 2 mM KH2PO4, 2.5 mM MgCl2 and
10mMHEPES-KOH pH 7.2 or in media inwhich all Kþ salts were substituted by Naþ.
Except for basal assays, mitochondria were energized with 2 mM succinate and
1 mg/ml oligomycin was included to inhibit DJ variations resulting from ATP syn-
thesis by the FoF1-ATP synthase, as well as regulation of mitochondrial ROS pro-
duction by this enzyme (Shertzer et al., 2006; Veenman et al., 2010). In some
experiments, 3 mM rotenone was added to inhibit reverse electron transfer from
complex succinate-reduced II to complex I. Additionally, 1 mM ATP, 150 mM 5-HD
and/or 30 mM DZX were also added to the reaction buffer (please see table and
figure legends for further details). When used, DZX was added to the suspension 2 s
aftermitochondria to ensure an evenmedia distribution. It should also be noted that
DZX is ineffective unless ATP is already present, because a channel opener will not
act on an already open channel (Facundo et al., 2007). Similarly, 5-HD is ineffective
unless ATP and a channel opener, such as DZX, are already present because 5-HD
alone does not block the channel, but rather prevents the effect of diazoxide
(Jaburek et al., 1998). Light-scattering recordings were initiated by the addition of
mitochondria and followed for more than 200 s. Data was analyzed using the
software FL WinLab provided by the manufacturer (PerkinElmer Life and Analytical
Sciences, Boston, MA).
2.8. Measurement of hydrogen peroxide production
The production of H2O2 by the respiratory chain and modulation by mitoKATP
was evaluated fluorometrically using the fluorescent probe Amplex Red, as
described previously (Facundo et al., 2007; Zhou et al., 1997) with some modifica-
tions. Briefly, Amplex Red (SigmaeAldrich, St. Louis, MO) was dissolved in DMSO to
achieve a concentration of 10 mM; horseradish peroxidase type VI-A (HRP, Sigmae
Aldrich, St. Louis, MO) was prepared in reaction buffer (130 mM KCl, 2 mM KH2PO4,2.5 mMMgCl2 and 10 mM HEPES-KOH pH 7.2 or in media in which all Kþ salts were
substituted by Naþ) to a final concentration of 1550 U/ml, and were kept at 4 C
through the end of the experiments. All experiments were conducted in duplicate
using a Costar 96 wells black clear-bottom microplate (Corning, NY) with 100 mg
protein, 5 mM Amplex Red, 1 U/L peroxidase, 1ug/mL oligomycin and supplemented
with 200 mL buffer per well. Depending on the assay, 2 mM succinate, 1 mM ATP,
150 mM 5-HD and/or 30 mM DZX were added to the reaction medium. Sample
fluorescence was then followed for 10 min in intervals of 25 s at 37 C in a Spec-
traMax Gemini EM Fluorescence microplate reader (Molecular Devices, Sunnyvale,
CA) with 563 nm excitation and 587 nm emissionwavelengths (570 nm cut-off). The
rates of H2O2 production by rat heart mitochondria were obtained from the initial
slopes determined using software provided by the manufacturer (SoftMax Pro
version 5.0) and are plotted as fluorescence arbitrary units per second (A.U./s).
2.9. Data analyses and statistics
Data are presented as mean  SEM of three to five experiments conducted with
different and independents mitochondrial preparations. Comparisons between
control and treated were conducted using a Student’s t-test (one variable) or using
one-way ANOVA followed by specifics Bonferroni multiple comparison tests. Dif-
ferences were considered significant if: *p < 0.05; **p < 0.01 and ***p < 0.001.
Statistical analyses were performed using Graph Pad Prism version 5.
3. Results
3.1. Body and organs weight did not change in response of TCDD
After a single dose of 50 mg TCDD/kg body weight, no alterations
were observed in male Wistar rats body weight 24 h post-
treatment (Supplementary Table 1). The heart and liver weights
of treated animals did not differ from control animals which
resulted in unchanged organ weight/body weight (HW/BW and
LW/BW). Blood glucose was measured prior to the injections and
right before animal sacrifice. No alterations were found between
groups (Supplementary Table 1). Data also shows that acute
treatment with TCDD did not alter cardiac mitochondrial isolation
yield.
3.2. Effects of TCDD on cardiac and hepatic mitochondrial
bioenergetics
Oxygen consumption data on glutamate/malate- and succinate-
energized cardiac and liver mitochondria from control and treated-
animals are presented in Table 1. In the heart, a decrease in the RCR
value with glutamate-malate as mitochondrial substrate was
observed as a result of TCDD treatment (3.8  0.4 vs 2.7  0.4,
p ¼ 0.03), although no differences were found with succinate as
substrate (2.3  0.2 vs 1.8  0.1, p ¼ 0.14). Statistically significant
differences were also found in the ADP/O ratio in heart mitochon-
dria with the TCDD group having a lower value, but only when
succinate was used as substrate (2.1  0.2 nmolADP/natmsO vs
1.7  0.3 nmolADP/natmsO, p ¼ 0.04).
Interestingly, as opposed to the slight deterioration of cardiac
mitochondrial respiration, an apparent improvement in liver
mitochondrial function after TCDD was found (Table 1), charac-
terized by a significant increase in both state 3 (succinate,
205.0  46.7 natms O/min/mg prot vs 320.8  22.9 natms O/min/
mg prot, p¼ 0.04) and RCR (both substrates, for glutamate 4.6 0.3
vs 6.6  0.3 p ¼ 0.006 and for succinate 4.9  0.5 vs 6.1  0.2,
p ¼ 0.03). Also, decreased state 2 respiration was found in liver
mitochondria from TCDD-treated animals, when glutamate-malate
was used as substrate (43.1  5.1 natms O/min/mg prot vs
34.8  3.6 natms O/min/mg prot, p ¼ 0.03).
Cardiac mitochondria from DMSO-treated animals developed a
DJ around 220 mV (negative inside) after energization (Fig. 1).
TCDD treatment decreased maximal DJ generated by cardiac
mitochondria and caused an overall increase in liver mitochondria.
Nevertheless, the differences did not reach statistical significance
Table 1
Respiratory parameters in energized cardiac and hepatic rat mitochondria in the different experimental groups.
Glutamate/malate Succinate
Heart Liver Heart Liver
Control TCDD Control TCDD Control TCDD Control TCDD
State 2 (natms O/min/mg prot) 76.2  15.6 67.0  11.3 43.1  5.1 34.8  3.6* 152.0  28.1 123.0  15.0 42.2  8.1 47.9  2.9
State 3 (natms O/min/mg prot) 243.4  9.9 189.5  24.1 194.9  17.8 216.5  22.5 354.5  39.5 322.5  33.6 205.0  46.7 320.8  22.9*
State 4 (natms O/min/mg prot) 72.6  17.4 73.3  13.9 43.2  7.2 33.0  4.6 167.7  37.2 184.1  23.3 43.9  4.6 53.0  3.3
RCR 3.8  0.4 2.7  0.4* 4.6  0.3 6.6  0.3** 2.3  0.2 1.8  0.1 4.9  0.5 6.1  0.2*
ADP/O (nmol ADP/natoms O) 2.7  0.3 2.6  0.4 2.3  0.2 2.4  0.1 2.1  0.2 1.7  0.3* 2.1  0.3 1.9  0.3
Respiratory activities were measured polarographically with a Clark-type oxygen and in the presence of glutamate/malate or succinate. ADP (100 nM) was added to induce
state 3 respiration. The values are means  SEM of 3 (liver) and 4e5 (heart) independent experiments and were compared using paired Student’s t-test (control vs TCDD,
*p < 0.05; **p < 0.01).
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mitochondria (Fig. 1A, 224.4  2.7 mV vs -214.3  3.2 mV,
p ¼ 0.001). The phosphorylative lag phase (Fig. 1B) was also altered
by TCDD, causing an increase in the heart and a decrease in the
liver, although again statistical significance was only observed in
liver mitochondria for glutamate-malate (37.0 3.6 s vs 27.0 1.7 s,
p ¼ 0.04). Finally, ADP-induced depolarization was unaltered by
TCDD treatment in the heart and significantly increased after
treatment of liver mitochondria energized by glutamate-malate
(24.4  1.0 mV vs 27.0  0.3 mV, p ¼ 0.02).
3.3. Cardiac mitochondrial carbonyl groups increases with TCDD
treatment
The second objective of the present study was to investigate
whether TCDD treatment would result in increased oxidative stress
in addition to altering cardiac mitochondrial function. A significant
increase in protein carbonyls content was found in cardiac mito-
chondria from TCDD-treated rats (Fig. 2, 29120  1334 vs
33580  781, p ¼ 0.006). The presence of oxidized proteins in both
groups was confirmed by the specificity of DNPH, confirming that
TCDD causes cardiac mitochondrial oxidative damage. When
carbonyl groups were reduced to alcohols by using NaBH4, the
signal was significantly decreased, confirming once again the
specificity of the method.
3.4. MitoKATP activity is enhanced in the hearts of TCDD-treated
rats
Todirectlyassess ifmitoKATPactivitywasaltered inTCDD-treated
rats, light scattering variations were measured in mitochondrial
fractions from both experimental groups as previously described
(Facundo et al., 2007). Experiments were performed with succinate
alone since these experimental conditions are required to optimally
follow mitoKATP regulation by endogenous mitochondrial ROS
(Facundo et al., 2007). The traces in Fig. 3 are representative of vol-
ume alterations due to the opening and closing of mitoKATP in heart
mitochondria from control (Fig. 3A, CH) and treated rats (Fig. 3B, TH).
Succinate-energizedmitochondria rapidly accumulate Kþ, leading to
osmotic water entry and to a new steady-state volume, a process
requiring around 120 s at 37 C to be completed (Fig. 3). In the
absence of ATP (Fig. 3, control trace), mitoKATP are open and mito-
chondria accumulate Kþ and water to achieve a higher steady-state
volume than the one observed in the presence of ATP (Fig. 3, ATP
trace), which is explained by the inhibition of mitoKATP-dependent
Kþ uptake. Concomitant addition of diazoxide (Fig. 3, ATP þ DZX
trace) reverses ATP inhibition. As expected, no effects are observed
when DZX is added to mitochondria in the absence of ATP (data not
show), as mitoKATP are already in the open state (Facundo et al.,
2007). Effects of DZX are reversed by the addition of the mitoKATPinhibitor 5-hydroxydecanoate (Fig. 3, ATP þ DZX þ 5HD trace).
Importantly, only 30 mMDZXwas used in our experimental protocol,
a concentration that does not inhibit complex II activity (Dzeja et al.,
2003;Kowaltowski et al., 2001). Also, nodifferences inmitochondrial
swelling were observed in media without Kþ (Fig. 3A and B).
Swelling rate in cardiac mitochondria from TCDD-treated ani-
mals was significantly increased under control conditions, since TH
swelling rate was approximately 52% higher than the one observed
in the CH group (see Fig. 3A and B for typical traces, Fig. 4A for
average swelling rates, 0.86  0.06 edAbs/s vs 1.31  0.16 dAbs/s,
p < 0.01). However, DZX was more effective in re-opening mito-
KATP after ATP inhibition in TCDD-treated rats than in the control
group (0.72  0.12 dAbs/s vs 1.12  0.25 dAbs/s, p < 0.05). The
data suggests that mitoKATP activity is enhanced in the hearts of
TCDD-treated rats.
The activity of the channels was also measured as the total
variation in swelling amplitude, which was determined as the
difference between the value of light scattering detected at 120 s
(end of assay) and 62 s (2 s after the addition of mitochondrial
suspension). In general, swelling amplitude data reflected the same
trend as the data obtained from swelling rates, although the latter
appears to be more sensitive in detecting differences between
experimental groups (see Fig. 4A and B).We think that the apparent
lower sensitivity is due to the fact that CH and TH mitochondria
reach a very similar steady-state volume, although the kinetics of
volume alterations is different. When liver mitochondria from the
same animals were assayed for the same parameters, not only was a
minimal activity of mitoKATP in both control and treated groups
measured, but also no differences were found between the two
experimental groups (data not shown).
3.5. Mitochondrial H2O2 release due to mitoKATP channels is
decreased in the hearts of TCDD-treated rats
MitoKATP are regulated by themitochondrial redox state, which
result in an alteration of their channel activity, contributing to a
secondary regulation of mitochondrial ROS production. Because of
the decreased cellular antioxidant networks in the heart (as
compared with other tissues), heart mitochondria may be partic-
ularly susceptible to oxidative stress (Facundo et al., 2007), and thus
mitoKATP regulation of ROS production can be an extra protective
feature. We next aimed to correlate altered mitoKATP activity and
ROS production bymitochondria in cardiacmitochondria fromboth
control and TCDD-treated rats.
Under control conditions, respiratory chain H2O2 release rates
were lower than those observed in the presence of ATP, a potential
mitoKATP inhibitor (Fig. 5, CH control vs CH ATP: 5.59  0.92 vs
9.48  0.71, p < 0.001). The presence of ATP caused an increase in
H2O2 release by the respiratory chain, which was higher in DMSO-
treated than in TCDD-treated rats (Figs. 5, 69% vs 43% and CH ATP vs
Fig. 1. Effects of TCDD on mitochondrial membrane potential fluctuations: (A) mitochondrial maximal transmembrane electric potential developed (DJ, emV), (B) Phosphorylative
lag phase duration (s) and (C) ADP-induced depolarization (mV) assessed by a TPPþ-selective electrode in cardiac (H) and liver (L) mitochondria from control (CH, CL) and TCDD-
treated animals (TH, TL). Mitochondria were energized with glutamate/malate or succinate. The values are means  SEM of 3 (liver) and 4e5 (heart) independent preparations and
were compared using paired Student’s t-test (control vs TCDD, *p < 0.05; ***p < 0.001).
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Fig. 2. Detection of carbonyl groups on mitochondria from hearts from control (CH)
and TCDD-treated animals (TH). The carbonyl content was determined by immuno-
blotting. Left panel, representative result with () and (þ) meaning that the reaction
was made in the presence and absence of DNPH as described in materials and
methods. TH, treated heart; CH, control heart. Right panel, band density intensity of
the (þ) lanes. The values are means  SEM of 4 independently experiments and were
compared using paired Student’s t-test (control vs TCDD, **p < 0.01).
S.P. Pereira et al. / Environmental Pollution 180 (2013) 281e290286TH ATP, 9.48  0.71 vs 7.06  0.33, p < 0.01). DZX decreased the
production of H2O2 to control levels (Fig. 5, for example, CH
ATP þ DZX vs CH control, 7.23  0.50 vs 5.59  0.92, p > 0.05),
although the amount of H2O2 released by cardiac mitochondria
from TCDD-treated rats was lower (CH ATPþ DZX vs TH ATPþ DZX,
7.23  0.50 vs 5.16  0.49, p < 0.05). The agonist effect of DZX was
reversed by the addition of 5-HD. In this case, the release of H2O2
increased to values close to those found when ATP was present
(for example, CH ATP þ DZXþ5HD vs CH ATP, 8.71  0.72 vs
9.48  0.71, p > 0.05). Confirming the hypothesis that mitoKATP
activity contributes to a decrease of H2O2 release from the respi-
ratory chain, mitochondria incubated in Kþ-free, Naþ-rich media
presented higher H2O2 release rates (data not shown).
In liver mitochondria from the same experimental animals,
H2O2 release rates were higher in the presence of ATP, although noFig. 3. Mitochondrial ATP-sensitive Kþ transport. Isolated mitochondria (0.25 mg/ml) were
MgCl2 and 10 mM HEPES-KOH pH 7.2. In all experiments, the media contained also 2 mM su
mM rotenone was added. Decreases in light scattering due to mitochondrial Kþ and water
animals (CH); (B) representative traces for heart mitochondria from TCDD-treated rats (TH).
shown. For heart preparations, Kþ salts in the media were substituted with Naþ, as indicate
(ATP NaCl) conditions.differences existed between the control and TCDD-treated animals
(data not shown).4. Discussion
TCDD toxicity through AhR-independent mechanisms may
involve direct effects on mitochondria, thus leading to cellular
bioenergetic deficits. Themajor hypothesis of the current studywas
that TCDD causes mitochondrial dysfunction and oxidative stress in
rat heart, leading to an altered regulation of mitochondrial ATP-
sensitive Kþ channels (mitoKATP), which would become more
active and contribute to decrease the generation of free radicals by
the mitochondrial respiratory chain. Previous studies have shown
that lipid peroxidation and DNA damage can occur within 24 h of
treatment with TCDD (Stohs et al., 1986, 1991, 1990), even after a
single treatment of 50 mg TCDD/Kg body weight. For the present
study we used a high dosage of TCDD for a short interval as a model
for acute TCDD high exposure. The highest dosage ever recorded in
humans was 144,000 pg TCDD/g blood fat, which corresponds to a
calculated body burden of 1.6 mg TCDD and a dosage of 25 mg/kg
body weight (Geusau et al., 2001). Higher dosages used in rats in
the present and other studies (Bagchi et al., 1993; Choi et al., 2008;
Stohs et al., 1990) are justified by altered metabolism and clearance
of TCDD in rats vs humans, as previously described (Foster et al.,
2010). We should thus take in consideration that the results from
the present and above studies apply toward the effects of large
acute doses of TCDD and may not be so relevant toward the normal
environmental exposures at lower doses.
In our study, male Wistar rats injected with a single dose of
50 mg TCDD/Kg body weight did not exhibit changes in body and
organs weight 24 h after treatment. However, Stohs et al. (1991)
reported altered liver weight after a single oral dose of 100 mg
TCDD/Kg body weight at 3 days post treatment and a significant
decrease was reported in body weight on day 5 (Stohs et al., 1991).
The differences may be related with the time elapsed post-
treatment and with the dosage used.
The present work demonstrates that acute TCDD toxicity results
in some measurable alterations of cardiac mitochondrial function,added to a reaction medium at 37 C containing 130 mM KCl, 2 mM KH2PO4, 2.5 mM
ccinate (except in basal experiments) and 1 mg/ml oligomycin. For basal experiments, 3
uptake were measured. (A) Representative traces for heart mitochondria from control
One mM ATP, 30 mM diazoxide (DZX), 150 mM 5-hydroxydecanoate (5-HD) was added as
d in the corresponding traces, for the basal (basal NaCl), control (control NaCl) and ATP
Fig. 4. Effects of TCDD on heart mitoKATP channel activity. (A) swelling rate (dAbs/s) and (B) magnitude of light scattering variation in heart mitochondria (0.25 mg/ml) from
control (CH) and TCDD-treated (TH) rats, as followed in reaction medium (130 mM KCl, 2 mM KH2PO4, 2.5 mM MgCl2 and 10 mM HEPES-KOH pH 7.2). Where indicated, 2 mM
succinate, 1 mg/ml oligomycin, 1 mM ATP, 30 mM DXZ, or 150 mM 5-HD were present in the media. Swelling rate (A) was determined as the decrease in absorbance occurred after 2 s
incubation and during the next 60 s in Kþmedia supplied with the compounds described under the graph (þ). Control swelling rates in the presence of succinate were 0.86  0.04
for CH and 1.31  0.16 -dAbs/s for TH. The magnitude of swelling variation (B) was determined as the difference between the value of light scattering detected at 120 s (end of
experiment) and 62 s (2 s after the addition of mitochondrial suspension). Swelling performed with succinate resulted in a variation of 56.9  2.2 for CH and TH 73.3  7.5 arbitrary
units (A.U.). Comparisons were performed using one-way ANOVA, followed by Bonferroni multiple comparison, for the following paired observations inside the group of CH and TH:
basal vs control (B), control vs ATP (C), ATP vs ATP þ DXZ (#), ATP þ DZX vs ATP þ DZXþ5HD ($) (one symbol p < 0.05; two symbols p < 0.01; three symbols p < 0.001) and
between groups for the same condition: CH basal vs TH basal, CH control vs TH control, CH ATP vs TH ATP, CH ATP þ DZX vs TH ATP þ DZX, CH ATP þ DZX þ 5HD vs TH
ATP þ DZX þ 5HD (*p < 0.05; **p < 0.01; ***p < 0.001).
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chain and phosphorylative system. An end result of TCDD-induced
cardiac mitochondrial alterations may be decreased energy pro-
duction and inability to respond to stressful events by increased
energy output if normal function is not restored. Alterations in
cardiac mitochondrial function are accompanied by increased for-
mation of protein carbonyls (Fig. 2), a marker for oxidative stress,
which confirms that TCDD increases mitochondrial oxidative stress
and damage (Senft et al., 2002).
The next step was to investigate whether increased mitochon-
drial oxidative stress, besides contributing to cardiac mitochondrial
degeneration, can also alter the regulation of the cardiac mitoKATP.
Most studies characterizing mitoKATP activity and regulation have
been conducted using heart mitochondria due to their higher ac-
tivity (Facundo et al., 2007). Despite the fact the majority of reports
link increased mitoKATP activity to a decrease in oxidative stress
(Facundo et al., 2005), others have pointed out that channel activity
may actually result into increased mitochondrial free radical pro-
duction (Andrukhiv et al., 2006). The fact that mitoKATP are regu-
lated by and regulate free radical production by the respiratory
chain may explain the controversy.The most used mitoKATP opener is diazoxide (DZX), although
this compound can also inhibit succinate dehydrogenase (CII) when
used at concentrations higher than 100 mM, i.e. above the concen-
tration needed to open mitoKATP in isolated mitochondria (Dzeja
et al., 2003; Facundo et al., 2007). MitoKATP opening can be
inhibited by 5-hydroxydecanoic acid (5-HD), although some authors
report that 5-HD can also affectmitochondrial respiration (Lim et al.,
2002) and inhibit fatty acid oxidation (Hanley et al., 2005). The ef-
fects of openers and blockers of mitoKATP appear to be modulated
by the metabolic state and by the thiol redox status of mitochondria
(Facundo et al., 2007; Garlid, 1996). Modulation of mitoKATP
opening and closure contributes to regulate mitochondrial function.
The channels are involved in the regulation of Kþ transport across
the inner mitochondrial membrane, controlling mitochondrial
transmembrane potential, matrix osmotic pressure and volume
(Facundo et al., 2005). Opening of mitoKATP dissipates the inner
mitochondrial membrane potential (Holmuhamedov et al., 2004),
and increases matrix volume under physiological conditions or
when respiration is inhibited (Kowaltowski et al., 2001).
MitoKATP opening prevents the generation of mitochondrial
ROS (Forbes et al., 2001), although this idea still raises some debate.
Fig. 5. MitoKATP activity appears to decrease H2O2 release in the heart (A). Cardiac mitochondria (100 mg) from control (CH) or TCDD-treated (TH) rats were added to the reaction
media (130 mM KCl, 2 mM KH2PO4, 2.5 mM MgCl2 and 10 mM HEPES-KOH pH 7.2) in the presence of 5 mM Amplex Red, 1U/L. Depending on the experiment, 2 mM succinate, 1 mg/
ml oligomycin, 1 mM ATP, 30 mM DXZ, or 150 mM 5-HD were added to the reaction medium. H2O2 release was measured during 30 min at 37 C. H2O2 release rate was determined
between 10 and 20 min in Kþ media supplied with the compounds described under the graph (þ). Succinate-dependent H2O2 release resulted in a rate of 5.6  0.9 A.U. for CH and
4.9  0.8 for TH. Comparisons were performed using one-way ANOVA, followed by Bonferroni multiple comparison, for the following paired observations inside the group, for
example for cardiac mitochondria, CH and TH: basal vs control (B), control vs ATP (C), ATP vs ATP þ DXZ (#), ATP þ DZX vs ATP þ DZXþ5HD ($) (one symbol p < 0.05; two symbols
p < 0.01; three symbols p < 0.001) and between groups for the same condition: CH basal vs TH basal, CH control vs TH control, CH ATP vs TH ATP, CH ATP þ DZX vs TH ATP þ DZX,
CH ATP þ DZXþ5HD vs TH ATP þ DZXþ5HD (*p < 0.05; **p < 0.01; ***p < 0.001).
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mammalian cell types, as well as a major target organelle for
oxidative damage (Chomyn and Attardi, 2003). The mitoKATP may
function in a manner similar to mitochondrial uncoupling proteins
(Facundo et al., 2005; Hoerter et al., 2004), which are also activated
by oxidative stress, decreasing membrane potential to prevent
excessive mitochondrial ROS release (Facundo et al., 2005; Hoerter
et al., 2004). Since mitochondrial ROS are involved in regulating
pathologic and homeostatic cellular events, it is important to un-
derstand the signalling redox pathways involved in the mainte-
nance of proper mitochondrial ROS, including during exposure to
environmental chemicals such as TCDD.
Bymeasuring variations in light scattering asmeans to indirectly
followmitochondrial swelling, an increased activation of mitoKATP
in cardiac mitochondria from TCDD-treated rats was detected, the
effect being inhibited by mitoKATP antagonists ATP and 5-HD
(Figs. 3 and 4). The lack of observable mitochondrial swelling in
media without Kþ ions (Fig. 3A and B) provides unequivocal evi-
dence that this effect is related to a selective Kþ transport pathway
that promotes mitochondrial swelling and which can be attribut-
able tomitoKATP activity (Facundo et al., 2007). The findings appear
to be in accordance with previous results indicating that the
mitoKATP is a redox-sensitive channel with increased activity un-
der more oxidative conditions (Facundo et al., 2007; Liu et al.,
2002), which is demonstrated here to occur in TCDD-treated rats,
as seen by increased carbonyl groups (Fig. 1). Since mitoKATP have
been described to be activated when thiol groups are oxidized by
exogenous ROS (Zhang et al., 2001), it is logical to predict that
TCDD-induced increased ROS generation leads to the oxidation of
critical thiol residues and increased open channel probability.
Using cardiac isolated mitochondria (Fig. 5), the results appear
to suggest that mitochondrial ROS generation decreases when
mitoKATP is in the open state. MitoKATP-modulated oxygen free
radical production also exhibited the expected pharmacological
response, with the addition of ATP resulting in an increase of ROS
release, DZX reversing ATP inhibition and DZX effects being by itsturn reversed by the addition of the mitoKATP inhibitor 5-HD.
Mitochondria incubated in Kþ-free, Naþ-containing media pre-
sented higher H2O2 release rates. The data suggests that the mito-
KATP may be acting as a reactive oxygen species sensor that acts to
decrease mitochondrial free radical generation in response to
enhanced local levels of oxidants, as previously described (Facundo
et al., 2007). It has been previously suggested that the effects of DZX
on oxidative stress modulated by channel activity results from
succinate dehydrogenase inhibition (Facundo et al., 2007); in the
present study, a concentration of 30 mM of DZX was used, which is
three-fold lower than concentrations already described to inhibit
complex II (Dzeja et al., 2003; Kowaltowski et al., 2001). The
physiological mitoKATP agonist GTP decreases mitochondrial ROS
release only when ATP inhibits the channel and Kþ is available for
transport, confirming that mitoKATP activity prevents mitochon-
drial ROS release (Facundo et al., 2007). The protective activity of
mitoKATP is also supported by the fact that mitochondrial uncou-
pling resulting from expressing mitochondrial uncoupling proteins
(UCP) or frommild treatment with protonophores are also strongly
cardioprotective, decreasing oxidative stress (Hoerter et al., 2004).
Besides the possible mild mitochondrial uncoupling, activation of
mitoKATP can also protect mitochondria during stressful events
due to the promotion of mild mitochondrial swelling, which de-
creases the spatial distance between the inner and outer mito-
chondrial membranes, thus contributing to improve oxidative
metabolism and decreasing ROS production by the mitochondrial
respiratory chain (Facundo et al., 2006).
Contrary to our findings, some groups have proposed that
mitoKATP activity contributes to an increase in ROS release
(Andrukhiv et al., 2006). However, the increase is unrelated to the
mitoKATP and attributable to interferences in ROS measurements
using dichlorofluorescein in the presence of DZX (Facundo et al.,
2007). In our experiments, we used the specific, high sensitivity
and low noise probe Amplex Red, which is oxidized specifically by
HRP-bound H2O2 to form the fluorescent product resorufin
(Facundo et al., 2007; Zhou et al., 1997).
Fig. 6. Proposed interplay between cardiac mitoKATP and TCDD. From the data re-
ported in the present work, we propose that TCDD causes mitochondrial oxidative
stress, which can contribute to induce degeneration of mitochondrial function. It is
also likely that TCDD causes mitochondrial dysfunction by ROS-independent factors,
e.g. by altering mitochondrial membrane order. TCDD-induced oxidative stress signals
through the mitoKATP, increasing their open state probability. The mitoKATP will act
downstream to decrease ROS production by the respiratory chain and contribute to
decrease the overall oxidative mitochondrial environment, in an attempt to adapt to
TCDD increased oxidative stress. Circles with a “þ” sign (full lines in green) denote a
positive effect, while circles with a “” (dashed lines in red) denote a negative effect.
(For interpretation of the references to color in this figure legend, the reader is referred
to the web version of this article.)
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from TCDD-treated rats can contribute to the decrease in mito-
chondrial transmembrane potential in the hearts of treated rats,
although the results were only significant when succinate was used
as substrate. This is hardly surprising as it has been described that
the effects of mitoKATP on mitochondrial membrane potential
are not easily detected with conventional methods (Facundo
et al., 2006).
Despite the obvious advances in the understanding of mitoKATP
as a redox sensor during dioxin-induced mitochondrial toxicity, a
few limitations exist in the present work. One includes the mech-
anisms of TCDD-induced oxidative stress on cardiac mitochondria.
It has been reported that TCDD causes oxidative stress on liver
mitochondria although the authors could not exactly pinpoint the
exact mechanism of increased ROS generation (Senft et al., 2002).
The second limitation is to identify the links between TCDD-
induced oxidative stress, increased mitoKATP activation and
consequent response by decreasing ROS production by mitochon-
dria, which to be fair is not a solo limitation of the present work,
since the literature is far from an agreement (Andrukhiv et al.,
2006; Facundo et al., 2007).
In conclusion, this study indicates that acute TCDD toxicity
causes negative alterations on heart mitochondria and enhanced
carbonylation of proteins. TCDD also caused an alteration of mito-
KATP modulation, which appears to result in a decreased produc-
tion of ROS by the mitochondrial respiratory chain in the treated
animals. Independent of the controversy regarding the activity of
mitoKATP, our results appear to suggest that the activity of these
channels may decrease mitochondrial ROS release. Our data and
that of others suggest that mitoKATP regulate ROS generation, thus
minimizing ROS-induced oxidative damage caused by TCDD to
mitochondrial structures, which is already apparent from increased
protein carbonylation (Fig. 6). On the other hand, the present work
highlights the need to explore alternative targets of known xeno-
biotics, that are known to cause oxidative stress in mitochondria,
and which may alter the regulation of the mitoKATP and thus cause
physiological alterations which may positively or negatively impact
the outcome of toxicant interactions.
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